Market Analysts see Elanco Animal Health Incorporated [ELAN] falling to $22. Time to buy?

Elanco Animal Health Incorporated [NYSE: ELAN] surged by $0.42 during the normal trading session on Monday and reaching a high of $13.5399 during the day while it closed the day at $13.45. The company report on October 11, 2022 that Elanco Confirms Date and Conference Call for Third Quarter 2022 Financial Results Announcement.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2022 financial results on Tuesday, November 8, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance.

The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco’s website at https://investor.elanco.com/events-and-presentations/default.aspx. A replay will also be available on the website shortly following the call.

Elanco Animal Health Incorporated stock has also gained 1.97% of its value over the past 7 days. However, ELAN stock has declined by -29.69% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.42% and lost -52.61% year-on date.

The market cap for ELAN stock reached $6.33 billion, with 488.40 million shares outstanding and 472.95 million shares in the current float. Compared to the average trading volume of 7.27M shares, ELAN reached a trading volume of 7365842 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Elanco Animal Health Incorporated [ELAN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $20.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Elanco Animal Health Incorporated shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on August 18, 2022. While these analysts kept the previous recommendation, JP Morgan dropped their target price from $28 to $24. The new note on the price target was released on August 16, 2022, representing the official price target for Elanco Animal Health Incorporated stock. Previously, the target price had yet another drop from $32 to $19, while Goldman kept a Sell rating on ELAN stock.

The Average True Range (ATR) for Elanco Animal Health Incorporated is set at 0.56, with the Price to Sales ratio for ELAN stock in the period of the last 12 months amounting to 1.36. The Price to Book ratio for the last quarter was 0.92, with the Price to Cash per share for the same quarter was set at 1.08. Price to Free Cash Flow for ELAN in the course of the last twelve months was 14.87 with Quick ratio for the last quarter at 1.50.

ELAN stock trade performance evaluation

Elanco Animal Health Incorporated [ELAN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.97. With this latest performance, ELAN shares gained by 9.53% in over the last four-week period, additionally sinking by -38.42% over the last 6 months – not to mention a drop of -60.55% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 55.55, with the RSI for the last a single of trading hit 61.77, and the three-weeks RSI is set at 50.01 for Elanco Animal Health Incorporated [ELAN]. The present Moving Average for the last 50 days of trading for this stock 13.41, while it was recorded at 13.15 for the last single week of trading, and 20.90 for the last 200 days.

Elanco Animal Health Incorporated [ELAN]: An insightful look at the core fundamentals

Elanco Animal Health Incorporated’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 2.50.

Earnings per share (EPS) analysis for Elanco Animal Health Incorporated [ELAN] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Incorporated go to 9.00%.

Elanco Animal Health Incorporated [ELAN]: Insider Ownership positions

There are presently around $6,240 million, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 49,206,190, which is approximately 72.124% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 42,476,178 shares of the stock with an approximate value of $571.3 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $410.92 million in ELAN stock with ownership of nearly -0.756% of the company’s market capitalization.

Positions in Elanco Animal Health Incorporated stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 207 institutional holders increased their position in Elanco Animal Health Incorporated [NYSE:ELAN] by around 50,507,503 shares. Additionally, 238 investors decreased positions by around 53,757,321 shares, while 60 investors held positions by with 359,652,988 shares. The mentioned changes placed institutional holdings at 463,917,812 shares, according to the latest SEC report filing. ELAN stock had 52 new institutional investments in for a total of 3,299,676 shares, while 91 institutional investors sold positions of 10,145,359 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here